RYOIX Mutual Fund
RYOIX Mutual Fund
RYOIX Mutual Fund
Rydex Biotechnology Fund Investor Class
RYOIX Mutual Fund Overview
RYOIX Mutual Fund (Rydex Biotechnology Fund Investor Class) is managed by Rydex Funds with $134.0M in net assets. RYOIX expense ratio is 1.38%, holding 72 positions across sectors including Health Care. Inception date: 1998-04-01.
RYOIX performance shows a YTD return of 31.34%. The 1-year return is 39.61% and the 5-year return is 8.83%.
RYOIX top holdings include Abbvie Inc. (7.9%), Amgen Inc. (5.7%), Gilead Sciences Inc (4.9%), Vertex Pharmaceuticals Inc (4.5%), Moderna Inc (4.1%). Go to all RYOIX holdings, RYOIX sectors, or RYOIX dividends.
RYOIX can be compared against other funds. Use RYOIX overlap to find shared positions, or RYOIX vs another fund for a side-by-side view. RYOIX alternatives are available via the screener, along with tax-loss harvesting opportunities.